Evaluation
*
Very PoorPoorNeutralGoodExcellent
Overall Evaluation
Content
Usefulness
Quality
*
(1=Strongly Disagree, 5= Strongly Agree)
12345
Discuss treatment guidelines and recommendations for appropriate patient assessment, treatment selection, and risk stratification strategies within dyslipidemia.
Analyze available and emerging dyslipidemia therapeutics, including statin therapy and PCSK9 inhibitors.
Formulate personalized treatment plans to accurately assess patient-specific characteristics, optimizing therapeutic selection to improve outcomes in dyslipidemia.
*
*
(1=NOT at all confident, 2=Somewhat confident, 3=Confident, 4=Very confident, 5=EXTREMELY confident, N/A=Not within the scope of my practice)
12345N/A
Develop individualized treatment plans for patients with dyslipidemia?
Apply current ACC/AHA guidelines to your everyday practice?
*
*
*
(1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable to me)
12345N/A
Utilize current recommendations and guidelines when managing patients with dyslipidemia
Consider the application of PCSK9 therapeutics for patients with statin intolerance
Apply knowledge from clinical trial data to develop individualized treatment plans to maximize patients at LDL-C goals